NO923824L - USE OF TRINITROBENZENES OR CARCAMIC ACID IN TREATMENT OF CANCER OR VIRUS DISEASES - Google Patents
USE OF TRINITROBENZENES OR CARCAMIC ACID IN TREATMENT OF CANCER OR VIRUS DISEASESInfo
- Publication number
- NO923824L NO923824L NO92923824A NO923824A NO923824L NO 923824 L NO923824 L NO 923824L NO 92923824 A NO92923824 A NO 92923824A NO 923824 A NO923824 A NO 923824A NO 923824 L NO923824 L NO 923824L
- Authority
- NO
- Norway
- Prior art keywords
- group
- carcamic
- trinitrobenzenes
- cancer
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Anvendelse l terapi eller profylakse av neoplasmer eller vlral-lnfeksjoner hos mennesker eller dyr av en formulering omfattende en forbindelse oppløst eller dispergert i et vandig medium ved en konsentrasjon innen området 10~3 til 10~15 mol/1 og med den generelle formel: der X er valgt blant OH, NB2, halogen, en sulfogruppe, en karboksylgruppe, QCE$ eller en substituert eller usubstituert hydrazylgruppe med formelen: Z - N - N - l l Y A der A er hydrogen eller et uparet elektron på nitrogen- atomet, Y er hydrogen eller en organisk gruppe og 2 er en organisk gruppe, eller Y og Z sammen med det nærliggende nitrogenatom danner en nltrogenholdig heterocykel; forutsatt at når X er en substituert eller usubstituert hydrazylgruppe som nevnt ovenfor kan en av N02-gruppene være erstattet med en sulfogruppe.Use in therapy or prophylaxis of neoplasms or viral infections in humans or animals of a formulation comprising a compound dissolved or dispersed in an aqueous medium at a concentration within the range of 10 ~ 3 to 10 ~ 15 mol / l and of the general formula: X is selected from OH, NB2, halogen, a sulfo group, a carboxyl group, QCE $ or a substituted or unsubstituted hydrazyl group of the formula: Z - N - N - 11 YA where A is hydrogen or an unpaired electron on the nitrogen atom, Y is hydrogen or an organic group and 2 is an organic group, or Y and Z together with the nearby nitrogen atom form a nitrogen-containing heterocycle; provided that when X is a substituted or unsubstituted hydrazyl group as mentioned above, one of the NO 2 groups may be replaced by a sulfo group.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909007453A GB9007453D0 (en) | 1990-04-03 | 1990-04-03 | Tumour therapy |
GB909012166A GB9012166D0 (en) | 1990-05-31 | 1990-05-31 | Hydrazine derivatives for cancer therapy |
GB919103075A GB9103075D0 (en) | 1991-02-13 | 1991-02-13 | Trinitrobenzene derivatives and their therapeutic use |
PCT/GB1991/000517 WO1991015200A2 (en) | 1990-04-03 | 1991-04-03 | Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
NO923824D0 NO923824D0 (en) | 1992-10-01 |
NO923824L true NO923824L (en) | 1992-11-26 |
Family
ID=27265028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92923824A NO923824L (en) | 1990-04-03 | 1992-10-01 | USE OF TRINITROBENZENES OR CARCAMIC ACID IN TREATMENT OF CANCER OR VIRUS DISEASES |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0524212A1 (en) |
JP (1) | JPH06501449A (en) |
AU (1) | AU662883B2 (en) |
BR (1) | BR9106310A (en) |
CA (1) | CA2079803A1 (en) |
FI (1) | FI924475A7 (en) |
HU (1) | HUT62785A (en) |
LV (1) | LV10574B (en) |
MC (1) | MC2246A1 (en) |
NO (1) | NO923824L (en) |
WO (1) | WO1991015200A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9103075D0 (en) * | 1991-02-13 | 1991-03-27 | Washington Odur Ayuko | Trinitrobenzene derivatives and their therapeutic use |
US5412123A (en) * | 1993-02-08 | 1995-05-02 | Glycomed Incorporated | Anthraquinone and anthracene derivatives as inhibitors of the cell-adhesion molecules of the immune system |
GB2284153B (en) * | 1993-05-21 | 1998-02-25 | Radopath Ltd | Substances for use in treatment of HIV-infection in HIV-infected patients |
GB9310520D0 (en) | 1993-05-21 | 1993-07-07 | Radopath Ltd | Arylating agents |
DZ1781A1 (en) * | 1993-05-21 | 2002-02-17 | Radopah Ltd | Arylating agents. |
AU1900195A (en) * | 1994-03-17 | 1995-10-03 | Radopath Limited | Anti-viral and anti-cancer agents |
AU5115396A (en) * | 1995-03-17 | 1996-10-08 | Radopath Limited | Anti-viral and anti-cancer agents |
GB9615619D0 (en) * | 1996-03-18 | 1996-09-04 | Radopath Ltd | Costimulation of TcR/CD3-induced T-Lymphocytes |
WO1999029706A2 (en) * | 1997-12-08 | 1999-06-17 | Glycomed Incorporated | DISALICYLATE ANALOG BASED SIALYL LEWISx MIMETICS |
EP3824031A1 (en) * | 2018-07-17 | 2021-05-26 | Pili | Anthraquinonic derivatives and their use as colouring agents |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4032659A (en) * | 1969-03-20 | 1977-06-28 | American Home Products Corporation | Method of viral chemoprophylaxis |
CA1262864A (en) * | 1982-09-17 | 1989-11-14 | Clarence D. Cone | Method for producing oncolysis |
FR2622445B1 (en) * | 1987-10-30 | 1990-07-27 | Pasteur Institut | APPLICATION OF NITROPHENYL GROUPS TO STIMULATE THE CAPACITIES OF INCORPORATION OF A DRUG IN SENSITIVE HOST CELLS |
-
1991
- 1991-04-03 AU AU75604/91A patent/AU662883B2/en not_active Ceased
- 1991-04-03 BR BR919106310A patent/BR9106310A/en not_active Application Discontinuation
- 1991-04-03 HU HU923148A patent/HUT62785A/en unknown
- 1991-04-03 CA CA002079803A patent/CA2079803A1/en not_active Abandoned
- 1991-04-03 WO PCT/GB1991/000517 patent/WO1991015200A2/en not_active Application Discontinuation
- 1991-04-03 JP JP3506514A patent/JPH06501449A/en active Pending
- 1991-04-03 MC MC91GB9100517D patent/MC2246A1/en unknown
- 1991-04-03 EP EP91907059A patent/EP0524212A1/en not_active Withdrawn
- 1991-04-03 FI FI924475A patent/FI924475A7/en not_active Application Discontinuation
-
1992
- 1992-10-01 NO NO92923824A patent/NO923824L/en unknown
- 1992-10-05 LV LVP-92-149A patent/LV10574B/en unknown
Also Published As
Publication number | Publication date |
---|---|
FI924475A0 (en) | 1992-10-05 |
FI924475L (en) | 1992-10-05 |
NO923824D0 (en) | 1992-10-01 |
AU7560491A (en) | 1991-10-30 |
FI924475A7 (en) | 1992-10-05 |
HUT62785A (en) | 1993-06-28 |
HU9203148D0 (en) | 1992-12-28 |
MC2246A1 (en) | 1993-03-25 |
AU662883B2 (en) | 1995-09-21 |
EP0524212A1 (en) | 1993-01-27 |
WO1991015200A2 (en) | 1991-10-17 |
CA2079803A1 (en) | 1991-10-04 |
JPH06501449A (en) | 1994-02-17 |
WO1991015200A3 (en) | 1992-03-05 |
LV10574A (en) | 1995-04-20 |
BR9106310A (en) | 1993-04-20 |
LV10574B (en) | 1995-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200100772A1 (en) | BENZOHETEROCYCLES AND THEIR APPLICATION AS MEK INHIBITORS | |
DK0738270T3 (en) | Dihydropyrazolopyrroles | |
NZ503432A (en) | Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function | |
FI73986B (en) | ANALOGIFICANT FARING FOR FRAMSTAELLNING AV 1-PIPERAZINKARBOXAMIDER. | |
NO940523L (en) | New pyrazine derivatives | |
NO923824L (en) | USE OF TRINITROBENZENES OR CARCAMIC ACID IN TREATMENT OF CANCER OR VIRUS DISEASES | |
SE8204237L (en) | CARBOSTYRIC ASSOCIATIONS, COMPOSITIONS CONTAINING THESE AND THE PROCEDURES FOR PREPARING THEREOF | |
NO142400C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NEW BENZIMIDAZOLINON DERIVATIVES | |
SE8504014L (en) | ETYLENDIAMINMONOAMID DERIVATIVES | |
DK0612731T3 (en) | New quinolone and naphthyridone carboxylic acid derivatives | |
ES8202015A1 (en) | Penem-3-carboxylic acid derivatives, their preparation and use | |
SE7811455L (en) | 2-IMINO-IMIDAZOLIDINE DERIVATIVE | |
ES452602A1 (en) | PROCEDURE FOR THE PREPARATION OF NEW PIPERIDINE TETRACICLIC DERIVATIVES. | |
ES454085A1 (en) | Procedure for the preparation of N- (r-tetrahydrofurfuril) -noroximorphone and N- (s-tetrahydrofurfuril) -noroximorphone new. (Machine-translation by Google Translate, not legally binding) | |
SE8005784L (en) | Heterocyclic Associations | |
JPS54128588A (en) | Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline | |
DE3778642D1 (en) | THERAPEUTIC FOR TREATMENT OF STOMACH. | |
LV10098A (en) | Derivatives of methylpiperazinepeptin by their acquisition and use | |
JPS549240A (en) | New derivative of phenylglycolic acid, its preparation and analgesic and antiinflammatory agent contining it as effective component | |
ATE207063T1 (en) | URACIL DERIVATIVES | |
JPS5331669A (en) | Novel n-acylpiperidinecaroxyanilide derivatives and their preparation | |
JPS5239674A (en) | Imidazole derivatives and agricultural bactericides therefrom | |
EP0486687A4 (en) | Quinolonecarboxylic acid derivatives | |
FR2608044B1 (en) | AQUEOUS ANTIBIOTIC COMPOSITION FOR VETERINARY USE | |
GB1069937A (en) | N-(halopyruvoyl)-nitroanilides |